Linda Wietecha Selected Research

Sluggish Cognitive Tempo

1/2017	Atomoxetine-Related Change in Sluggish Cognitive Tempo Is Partially Independent of Change in Attention-Deficit/Hyperactivity Disorder Inattentive Symptoms.
11/2013	Atomoxetine improved attention in children and adolescents with attention-deficit/hyperactivity disorder and dyslexia in a 16 week, acute, randomized, double-blind trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Linda Wietecha Research Topics

Disease

7	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2017 - 12/2009
4	Dyslexia (Alexia) 01/2017 - 12/2009
2	Migraine Disorders (Migraine) 01/2022 - 12/2018
2	Sluggish Cognitive Tempo 01/2017 - 11/2013
1	Headache (Headaches) 12/2018
1	Pain (Aches) 12/2018
1	Wounds and Injuries (Trauma) 09/2010

Drug/Important Bio-Agent (IBA)

7	Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric 01/2017 - 12/2009
1	galcanezumabIBA 01/2022
1	lasmiditanIBA 12/2018
1	Pain-FreeIBA 12/2018
1	TeaIBA 12/2009

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 01/2017